A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT01633970 · COMPLETED
Trial details
- NCT number
- NCT01633970
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-11
- Primary completion
- 2020-02-26
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.